Torrent Pharmaceuticals

TORNTPHARM · NSE · INR

₹4,767.30Change from previous close: −0.68%Absolute change: −₹32.70

Close · October 1, 2026

Company profile

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Country
India
Headquarters
Avirat, Thaltej Shilaj Road, 380059, Ahmedabad
Employees
18,258
Listing
TORNTPHARM · NSE
Currency
INR
ISIN
INE685A01028